EP2709646A4 - DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS - Google Patents

DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS

Info

Publication number
EP2709646A4
EP2709646A4 EP12785744.9A EP12785744A EP2709646A4 EP 2709646 A4 EP2709646 A4 EP 2709646A4 EP 12785744 A EP12785744 A EP 12785744A EP 2709646 A4 EP2709646 A4 EP 2709646A4
Authority
EP
European Patent Office
Prior art keywords
dry powder
associated methods
powder compositions
vancomycin
vancomycin dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12785744.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2709646A1 (en
Inventor
John Lord
Jaakko Taneli Jouhikainen
Herman E Snyder
Pravin Soni
Mei-Chang Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Savara Inc
Original Assignee
Savara Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savara Inc filed Critical Savara Inc
Publication of EP2709646A1 publication Critical patent/EP2709646A1/en
Publication of EP2709646A4 publication Critical patent/EP2709646A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP12785744.9A 2011-05-19 2012-05-21 DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS Withdrawn EP2709646A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161487971P 2011-05-19 2011-05-19
PCT/US2012/038775 WO2012159103A1 (en) 2011-05-19 2012-05-21 Dry powder vancomycin compositions and associated methods

Publications (2)

Publication Number Publication Date
EP2709646A1 EP2709646A1 (en) 2014-03-26
EP2709646A4 true EP2709646A4 (en) 2015-05-13

Family

ID=47177374

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12785744.9A Withdrawn EP2709646A4 (en) 2011-05-19 2012-05-21 DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS

Country Status (11)

Country Link
EP (1) EP2709646A4 (enrdf_load_stackoverflow)
JP (1) JP6012716B2 (enrdf_load_stackoverflow)
KR (1) KR101763195B1 (enrdf_load_stackoverflow)
CN (1) CN103717231B (enrdf_load_stackoverflow)
AU (1) AU2012254999B2 (enrdf_load_stackoverflow)
BR (1) BR112013029803B1 (enrdf_load_stackoverflow)
CA (2) CA2836643C (enrdf_load_stackoverflow)
IL (1) IL229506B (enrdf_load_stackoverflow)
MX (1) MX346244B (enrdf_load_stackoverflow)
SG (1) SG195038A1 (enrdf_load_stackoverflow)
WO (1) WO2012159103A1 (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007067520A2 (en) 2005-12-08 2007-06-14 Transave, Inc. Lipid-based compositions of antiinfectives for treating pulmonary infections
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
EP3581186A1 (en) * 2012-11-29 2019-12-18 Insmed Incorporated Stabilized vancomycin formulations
CN105142624A (zh) 2013-01-10 2015-12-09 普尔莫凯恩股份有限公司 非选择性激酶抑制剂
CN104043104B (zh) * 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
JP6483714B2 (ja) 2013-10-11 2019-03-13 ローレンス エス． ジスマン， 噴霧乾燥製剤
KR20160119259A (ko) * 2014-02-28 2016-10-12 알지파마 에이에스 낭포성 섬유증 및 cftr 이온 채널의 기능 결함과 관련된 기타 병태의 치료제로서 알기네이트 올리고머의 용도
EP4000628A1 (en) 2014-03-14 2022-05-25 Azurity Pharmaceuticals, Inc. Composition and method for vancomycin oral liquid
NZ726256A (en) 2014-05-15 2022-11-25 Insmed Inc Methods for treating pulmonary non-tuberculous mycobacterial infections
HUE053347T2 (hu) * 2014-11-06 2021-06-28 Xellia Pharmaceuticals Aps Glikopeptid-készítmények
JP6832281B2 (ja) * 2015-02-06 2021-02-24 ラティチュード ファーマシューティカルズ インコーポレイテッド バンコマイシンの水溶液製剤
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
CN110087653A (zh) 2016-10-27 2019-08-02 普尔莫凯恩股份有限公司 用于治疗肺高血压的组合疗法
CN106963939A (zh) * 2017-03-22 2017-07-21 永信药品工业（昆山）股份有限公司 盐酸万古霉素药物组合物及其制备方法
EP3634464A4 (en) 2017-05-22 2021-04-07 Insmed Incorporated GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
US20200115412A1 (en) * 2018-10-15 2020-04-16 Savara Inc. Separation of vancomycin and its degradation products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041833A1 (en) * 1996-05-08 1997-11-13 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
WO2001013893A2 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
WO2001032144A1 (en) * 1999-10-29 2001-05-10 Inhale Therapeutic Systems, Inc. Dry powder compositions having improved dispersivity
WO2003037303A1 (en) * 2001-11-01 2003-05-08 Nektar Therapeutics Spray drying methods and compositions thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES286422Y (es) 1982-10-08 1986-09-16 Glaxo Group Limited Dispositivo para administrar medicamentos a pacientes
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
JPH03193735A (ja) * 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
JP4142149B2 (ja) * 1997-07-10 2008-08-27 明治製菓株式会社 バンコマイシンの凍結乾燥製剤
DE10358387A1 (de) * 2003-12-13 2005-07-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
KR20110091510A (ko) * 2008-10-07 2011-08-11 엠펙스 파마슈티컬즈, 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
WO2010111641A2 (en) 2009-03-26 2010-09-30 Pulmatrix, Inc. Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis
CN108434126B (zh) * 2009-03-26 2021-11-19 普马特里克斯营业公司 治疗肺病的干粉配方与方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041833A1 (en) * 1996-05-08 1997-11-13 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
WO2001013893A2 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
WO2001032144A1 (en) * 1999-10-29 2001-05-10 Inhale Therapeutic Systems, Inc. Dry powder compositions having improved dispersivity
WO2003037303A1 (en) * 2001-11-01 2003-05-08 Nektar Therapeutics Spray drying methods and compositions thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Handbook of Pharmaceutical Excipients. Fifth Edition", 2006, PHARMACEUTICAL PRESS, article "Leucine", pages: 412, XP002729817 *
M. J. DE JESUS VALLE ET AL: "Pulmonary versus Systemic Delivery of Antibiotics: Comparison of Vancomycin Dispositions in the Isolated Rat Lung", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 51, no. 10, 6 August 2007 (2007-08-06), pages 3771 - 3774, XP055140353, ISSN: 0066-4804, DOI: 10.1128/AAC.00099-07 *
PRAJAKTA S. GADGILP: "A comparative study between high potency dry powder inhalation and nebulized solution of vancomycin hydrochloride for lung delivery", 11 August 2011 (2011-08-11), pages FP - 109, XP055140679, Retrieved from the Internet <URL:http://search.proquest.com/pqdtscieng/docview/889930798as02134> [retrieved on 20141111] *
REINHARD VEHRING: "Pharmaceutical Particle Engineering via Spray Drying", PHARMACEUTICAL RESEARCH, vol. 25, no. 5, 28 November 2007 (2007-11-28), KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, pages 999 - 1022, XP019613056, ISSN: 1573-904X *
See also references of WO2012159103A1 *

Also Published As

Publication number Publication date
EP2709646A1 (en) 2014-03-26
MX2013013503A (es) 2014-05-12
JP6012716B2 (ja) 2016-10-25
IL229506B (en) 2019-07-31
SG195038A1 (en) 2013-12-30
JP2014515356A (ja) 2014-06-30
KR101763195B1 (ko) 2017-07-31
BR112013029803A2 (pt) 2017-01-17
CA2981038C (en) 2018-09-25
MX346244B (es) 2017-03-13
NZ618002A (en) 2015-03-27
AU2012254999B2 (en) 2016-02-11
CN103717231A (zh) 2014-04-09
KR20140032450A (ko) 2014-03-14
CN103717231B (zh) 2016-08-17
BR112013029803B1 (pt) 2021-07-13
NZ704819A (en) 2016-05-27
CA2836643C (en) 2017-11-14
IL229506A0 (en) 2014-01-30
CA2836643A1 (en) 2012-11-22
CA2981038A1 (en) 2012-11-22
WO2012159103A1 (en) 2012-11-22

Similar Documents

Publication Publication Date Title
EP2709646A4 (en) DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS
EP2734049A4 (en) PROBIOTIC COMPOSITIONS AND METHOD
EP2648788A4 (en) dry powder inhaler
EP2720561A4 (en) Stevia-COMPOSITION
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2635282A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF MYELOFIBROSIS
EP2925298A4 (en) STABILIZED VANCOMYCIN FORMULATIONS
EP2709972A4 (en) NON-FLAMMABLE COMPOSITIONS FROM CHLORINE TRIFLUORPROPES
EP2675819A4 (en) COMPOSITIONS AND METHODS FOR MOLECULAR LABELING
PT2690951E (pt) Composições de ciclodextrina, artigos, e métodos
DK2696848T3 (da) Frysetørrede nanosuspensioner af lægemiddel
EP2897583A4 (en) COSMETIC SUSPENSION SPRAY COMPOSITIONS AND METHOD
BR112015009718A2 (pt) composição de matéria e artigo.
EP2785823A4 (en) CLEANING COMPOSITIONS AND METHODS
CO6980141A1 (es) Compuestos y composiciones de poliglicerilo catónicos
BR112014009802A2 (pt) composições de bismaleimida contendo nanossílica
BR112014006291A2 (pt) composição e utilização da composição
EP2691100A4 (en) INTRANASAL PHARMACEUTICAL BENZODIAZEPINE COMPOSITIONS
BR112013019287A2 (pt) composição inovadora de pesticidas
PT2736340T (pt) Biocontrolo de nemátodos
CO6940377A2 (es) Formulaciones de liofilizadas de fgf-18
EP2723390A4 (en) SERPINA1-SIRNAS: MATERIAL COMPOSITIONS AND TREATMENT PROCEDURES
EP2857482A4 (en) Perfume composition
EP2857421A4 (en) CELLULOSE POWDER
EP2922919A4 (en) COMPOSITIONS AND METHODS FOR REDUCING OXIDATIVE DAMAGES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131209

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1194310

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/14 20060101AFI20141114BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/14 20060101AFI20141121BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150415

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/14 20060101AFI20150409BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20161118

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220628

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1194310

Country of ref document: HK